NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1598925588 MD
Verify on CMS → Daniel Anderson, MD
Ophthalmology Physician in Spring, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,082 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
637
Medicare Part D claims · 212 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
59%
generic claims · 41% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
83.7/100
▲ 0 pts above national avg 83.5 · Above neutral
Industry payments
$1.8K
51 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Daniel Anderson, MD reported a CMS MIPS final score of 83.7/100 - above the 83.5 national average - and filed 637 Medicare Part D claims in 2023.
- 83.7/100
- MIPS score · +0 vs avg
- 637
- Part D claims, 2023
- 59%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Daniel Anderson, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1598925588), first enumerated 06/12/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 637 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 83.7/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$1.8K in reported industry payments (51 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Daniel Anderson, MD's individual license status. Verify directly with the state medical board.
Source: TMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1598925588 · Ophthalmology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-INLINE · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1598925588
- ENUM-MID 2008
- TAX-MID 22K Ophthalmology Physician
- MIPS-INLINE 83.7/100
- RX-LIGHT 637
- BOOK-LIGHT 1,408 in Texas
- PHOTO-FINISH Asima Bajwa · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Anderson · this …
Anderson · this provider
83.7 MIPS pts
- Julia Malalis · …
Julia Malalis
83.7 MIPS pts
- Asima Bajwa · near
Asima Bajwa
83.7 MIPS pts
- Omar Chaudhary ·…
Omar Chaudhary
83.7 MIPS pts
- James Heltzer · …
James Heltzer
83.7 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Daniel Anderson, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
84 ≥ 39th percentile 39% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Daniel Anderson, MD sits
This provider among ophthalmology physician peers
Across the 8,767 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Daniel Anderson, MD writes more Part D claims than 33% of them and scores higher on MIPS quality than 35% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Daniel Anderson, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Daniel Anderson, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Daniel Anderson, MD?
Near national averagePrimary specialty
Ophthalmology Physician
Medicare Part D claims
637 55% vs specialty avg
MIPS final score
83.7/100 0.2 pts vs avg
Specialty distribution in Texas
How Ophthalmology Physician compares to other specialties among Texas providers
Medicare quality performance, MIPS
Daniel Anderson, MD's 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 83.7/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1598925588 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/12/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
83.6675
Final Score
Measured-score avg: 83.5
90.458
Quality
63.0521
Cost
Reporting: Group practice
Hospital and facility affiliations
Facilities where Daniel Anderson, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Berkeley Eye Institute, PLLC
Houston, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Daniel Anderson, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.8K
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Daniel Anderson, MD. To verify Daniel Anderson, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Daniel Anderson, MD - brand share 41.0%
Ophthalmology Physician average
41% brand-name claims vs 59% generic, on 637 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
637
Total Claims
$77K
Total Drug Cost
212
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 837
- Total Day Supply
- 19,703
- Brand vs Generic
- 41% brand / 59% generic
- Brand Drug Cost
- $62K
- Generic Drug Cost
- $15K
- Antibiotic Claims
- 33
Patient Demographics
- Average Patient Age
- 73.4 years
- Avg HCC Risk Score
- 1.38
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 18, 65-74: 98, 75-84: 74, 85+: 22
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Daniel Anderson, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisolone Acetate
Prednisolone Acetate
136 claims
- Moxifloxacin
Moxifloxacin
126 claims
- Neomycin-Polymyxin…
Neomycin-Polymyxin-Dexameth
63 claims
- Latanoprost 43
Latanoprost
43 claims
- Valacyclovir 41
Valacyclovir
41 claims
- Doxycycline Hyclate 26
Doxycycline Hyclate
26 claims
- Erythromycin 26
Erythromycin
26 claims
- Combigan 18
Combigan
18 claims
| Drug | Claims |
|---|---|
| Prednisolone Acetate | 136 |
| Moxifloxacin Moxifloxacin Hcl | 126 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 63 |
| Latanoprost | 43 |
| Valacyclovir Valacyclovir Hcl | 41 |
| Doxycycline Hyclate | 26 |
| Erythromycin Erythromycin Base | 26 |
| Combigan Brimonidine Tartrate/Timolol | 18 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 16 |
| Restasis Cyclosporine | 15 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Daniel Anderson, MD fits within the Ophthalmology Physician landscape nationally.
22,082
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider
Daniel Anderson, MD's 637 claims are below the specialty average of 1,420.
Nationwide Ophthalmology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Anderson, both outside Texas so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (83.7 here).
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ophthalmology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Anderson.
One of 1,408 Ophthalmology Physician providers enrolled in Texas, 5 are shown here.
Dr. Justin Aaker
MD
Georgetown, TX
Dr. Asad Abbas
M.D.
Baytown, TX
Dr. Ashkan Abbey
M.D.
Dallas, TX
Dr. Meredith Abbott
MD
Dallas, TX
Dr. Musa Abdelaziz
MD
Southlake, TX
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Daniel Anderson, MD's specialty? ▼
Daniel Anderson, MD specializes in Ophthalmology Physician and practices in Spring, Texas. Credentials: MD.
How much does Daniel Anderson, MD prescribe under Medicare Part D? ▼
In 2023, Daniel Anderson, MD wrote 637 Medicare Part D claims totaling $77K in drug costs for 212 beneficiaries.
What is Daniel Anderson, MD's Medicare quality score? ▼
Daniel Anderson, MD has a CMS MIPS Final Score of 83.7/100 (Quality: 90.5, Cost: 63.1). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Daniel Anderson, MD located? ▼
Daniel Anderson, MD is located at 3929 WOODSONS RESERVE PKWY, Spring, TX, 77386. Phone: (346) 423-6443.
What is Daniel Anderson, MD's NPI number? ▼
Daniel Anderson, MD's National Provider Identifier (NPI) is 1598925588, issued on 06/12/2008.
Does Daniel Anderson, MD prescribe more brand-name or generic drugs? ▼
Daniel Anderson, MD's prescribing is 41% brand-name and 59% generic drugs by claim count, with $62K in brand drug costs.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,082 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does Daniel Anderson, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Daniel Anderson, MD's most frequently prescribed drugs include Prednisolone Acetate, Moxifloxacin, Neomycin-Polymyxin-Dexameth. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Daniel Anderson, MD accept Medicare? ▼
Daniel Anderson, MD appears in CMS Medicare data with 637 Part D claims and 212 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Daniel Anderson, MD's credentials? ▼
Daniel Anderson, MD's NPI is 1598925588 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.